BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 30

• 

  Deals

  Alumis Files for IPO to Fund Phase III Trials of Potential Rival Drug to BMS’ Sotyktu

  In an SEC filing on Friday, Alumis said it aims to start late-stage trials of a TYK2 inhibitor in plaque psoriasis this year and is seeking public funding for the studies.

  June 10, 2024

   · 

  2 min read

   · 

  Nick Paul Taylor
• 

  AI Enables Individualized Cancer Vaccines

  The use of artificial intelligence in the development of cancer vaccines allows for individualized therapy, but the prospect of an ever-changing product poses new challenges for drug developers and regulators.

  June 10, 2024

   · 

  5 min read

   · 

  Ben Hargreaves
• 

  Drug Development

  Adcomm Votes Unanimously for Lilly’s Alzheimer’s Treatment Donanemab

  Despite concerns raised in FDA briefing documents about Eli Lilly’s Alzheimer’s treatment, donanemab, the committee concluded that the benefits outweighed the risks.

  June 10, 2024

   · 

  2 min read

   · 

  Tyler Patchen